Understanding and overcoming resistance to immune checkpoint inhibitors will be key to furthering their rise in #oncology
pharmafeatures.com/overcomin…
Advancing #CGT will require innovation and collaboration, with a rethink of how #clinicaltrials for advanced therapies are conducted
pharmafeatures.com/advancing…
#genetherapy #oncology #cancer #rarediseases
The role of the #mitochondria in disease is just starting to be explored
pharmafeatures.com/mitochond…
#covid #Parkinsons #disease #biology
AAVs continue to lead the pack in #genetherapy vectors - especially for #rarediseases, but they still face significant challenges with immunogenicity, specificity, manufacturing and cost
lnkd.in/eRjcgXYF
Follow the movement of #money across the #pharmaindustry in the last week, with moves in drug discoveries, Novartis & PerkinElmer, Inc. partnering for sickle cell disease in Sub-Saharan Africa, and others!
pharmafeatures.com/pharma-in…
Alternative data sources present unique opportunities for #drugsafety - but also challenges; new technology will prove vital in harnessing the large data volumes in the field
#pharmacovigilance #bioinformatics #ai #bigdata
pharmafeatures.com/the-promi…
Phenotypic Drug Discovery methods have been rapidly evolving in the last few years - we discussed the main points of the approach with Brent Cezairliyan from @OctagonTx
pharmafeatures.com/trends-in…
#drugdiscovery #drugdevelopment #clinicaloperations
April saw multiple first-in-class drugs greenlit - with treatments for hypertrophic cardiomyopathies, Wilson's Disease, recurrent vulvovaginal candidiasis, and others
Follow us for a monthly roundup of the most exciting drug approvals!
pharmafeatures.com/april-202…
#drugdiscovery
We discussed emerging drug modalities with Venita de Almeida from @3tbio, such as antibody drug conjugates, PROTACs, and how novel #AI technologies in #DrugDiscovery can accelerate the development of future products
pharmafeatures.com/novel-dru…
#bioinformatics
Follow the movement of money in #pharma this week - with deals in #immunology, protein degraders, #neurology, #celltherapy and #GeneTherapy
pharmafeatures.com/pharma-in…
Hope is on the horizon for pancreatic #cancer with new #AI #diagnostics and novel #immunotherapies and oncolytic viruses
pharmafeatures.com/recent-de…
#oncology #drugdiscovery
#EndMalaria #ItTakesAFamily
Towards Zero Malaria: World Malaria Day 2022
pharmafeatures.com/towards-z…
2
Is zero malaria by 2030 possible? On #WorldMalariaDay the global concern for #Malaria - not just a disease for #SubSaharanAfrica, particularly with #climatechange - and the innovation needed to prevent and treat the disease
pharmafeatures.com/towards-z…
#InfectiousDiseases
Money movements in the #PharmaIndustry this week include high-profile partnerships and acquisitions from Regeneron, moves in the #PROTACs field by VantAI, #immunooncology and others
pharmafeatures.com/2974-2/
#investments #drugdiscovery #bioinformatics
Past and current #pandemics illuminate repeating patterns in social behaviour, public reactions and governmental responses - offering valuable insights for future #pandemicpreparedness
pharmafeatures.com/2967-2/
#pandemic #COVID19
In our interview with Zina Sadeq from Amicus Therapeutics we discussed how the impacts of the #COVIDー19 #pandemic as well as growing #AI adoption present a new world of opportunity - but also challenge - in #Pharmacovigilance
pharmafeatures.com/int-zina-…
#bioinformatics
See the way money moved in the week ending 14 April 2022, with developments in the #microbiome, #immunotherapy, #PROTACs and #AI
pharmafeatures.com/2954-2/
#drugdiscovery #bioinformatics #clinicalresearch
How much of the #ParkinsonsDisease puzzle are we still missing?
pharmafeatures.com/world-par…
#WorldParkinsonsDay #ParkinsonsAwarenessMonth #ParkinsonsAwarenessWeek
Just like #COVID19, collaboration will be key in cancer innovation. In our interview with Philip Beer from Step Pharma, we discuss the importance of #translationalmedicine approaches in #cancer treatment and care
pharmafeatures.com/int-phili…
The #COVIDー19 #pandemic remains unpredictable, with large outbreaks persisting in #China and record levels of infection in the UK. Government approaches are called into question, while research continues to shed new lights on the disease.
pharmafeatures.com/the-chang…

